← Leaderboards
J Timothy Greenamyre
Emory University
$15,296,340
Attributed
$15,296,340
Total exposure
19
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.4M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,404,336 · 21
By mechanism
R01$10,676,647 · 7
P01$7,951,572 · 3
U54$2,848,930 · 3
RC1$999,999 · 1
T32$834,649 · 1
R56$556,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Donald L. Bliwise$6,113,761
- J T Greenamyre$0
- Robert J McKeon$1,244,370
- James R Roede$5,558,881
- Mahlon R Delong$4,829,158
Others in their field
Top investigators on “Parkinson Disease”
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$92,426,001
- David M Anderson · University Of Washington$40,483,703
- Daniel M Corcos · Northwestern University$37,632,589
- Joel Synes Perlmutter · Washington University$37,192,743
- Jerrold L Vitek · University Of Minnesota$35,135,315
- Joseph B Martin · Harvard University (Medical School)$26,652,023
Research focus
Parkinson DiseaseMitochondriaNerve DegenerationRattusRotenonePathogenesisMutationComplexMitochondrial ProteinsBrainProteinsGeneticSubstantia Nigra StructureOxidative StressAlpha SynucleinRisk FactorsPathologyMediatingNeuronsDopaminergic NeuronOxidationOverexpressionImpairmentPlay
Grant awards (61)
LRRK2 and Oxidative Stress in Parkinsonâs Disease$490,660
R01 · FY2025 · NS · contact PI
LRRK2 and oxidative stress in Parkinsonâs disease$490,660
R01 · FY2024 · NS · contact PI
LRRK2 and oxidative stress in Parkinsonâs disease$556,500
R56 · FY2023 · NS · contact PI
Role of LRRK2 in idiopathic Parkinson's disease$342,344
R01 · FY2021 · NS · contact PI
Role of LRRK2 in idiopathic Parkinson's disease$342,344
R01 · FY2020 · NS · contact PI
alpha-Synuclein Inhibition of Mitochondrial Protein Import$474,360
R01 · FY2019 · NS · contact PI
Role of LRRK2 in idiopathic Parkinson's disease$342,344
R01 · FY2019 · NS · contact PI
2019 Parkinson's Disease Gordon Research Conference and Gordon Research Seminar$10,000
R13 · FY2019 · NS · contact PI
alpha-Synuclein Inhibition of Mitochondrial Protein Import$474,359
R01 · FY2018 · NS · contact PI
Role of LRRK2 in idiopathic Parkinson's disease$342,344
R01 · FY2018 · NS · contact PI
A slowly progressive, endogenous synucleinopathy model of Parkinson's disease$195,104
R21 · FY2018 · ES · contact PI
alpha-Synuclein Inhibition of Mitochondrial Protein Import$474,360
R01 · FY2017 · NS · contact PI
Role of LRRK2 in idiopathic Parkinson's disease$340,521
R01 · FY2017 · NS · contact PI
A slowly progressive, endogenous synucleinopathy model of Parkinson's disease$232,313
R21 · FY2017 · ES · contact PI
alpha-Synuclein Inhibition of Mitochondrial Protein Import$444,261
R01 · FY2016 · NS · contact PI
2017 Parkinson's Disease Gordon Research Conference and Seminar$29,900
R13 · FY2016 · NS · contact PI
MtDNA damage as a biomarker for environmental mitochondrial toxicity$760,075
R01 · FY2015 · ES · contact PI
alpha-Synuclein Inhibition of Mitochondrial Protein Import$360,408
R01 · FY2015 · NS · contact PI
DJ-1 in Astrocyte-Mediated Neuroprotection Against Complex I Inhibitors$340,875
R01 · FY2015 · ES · contact PI
MtDNA damage as a biomarker for environmental mitochondrial toxicity$446,200
R01 · FY2014 · ES · contact PI
MtDNA damage as a biomarker for environmental mitochondrial toxicity$337,466
R01 · FY2014 · ES · contact PI
DJ-1 in Astrocyte-Mediated Neuroprotection Against Complex I Inhibitors$337,466
R01 · FY2014 · ES · contact PI
Mitochondrial Proteins in Parkinson's Disease$1,223,987
P01 · FY2013 · NS · contact PI
Mechanisms & Consequences of Iron Accumulation in PD$371,980
P01 · FY2013 · NS · contact PI
MtDNA damage as a biomarker for environmental mitochondrial toxicity$334,058
R01 · FY2013 · ES · contact PI
DJ-1 in Astrocyte-Mediated Neuroprotection Against Complex I Inhibitors$334,058
R01 · FY2013 · ES · contact PI
Administrative Core$148,899
P01 · FY2013 · NS · contact PI
Mitochondrial Proteins in Parkinson's Disease$1,265,705
P01 · FY2012 · NS · contact PI
MtDNA damage as a biomarker for environmental mitochondrial toxicity$340,875
R01 · FY2012 · ES · contact PI
Mechanisms & Consequences of Iron Accumulation in PD$250,305
P01 · FY2012 · NS · contact PI
Administrative Core$31,737
P01 · FY2012 · NS · contact PI
Mitochondrial Proteins in Parkinson's Disease$1,263,110
P01 · FY2011 · NS · contact PI
MtDNA damage as a biomarker for environmental mitochondrial toxicity$340,875
R01 · FY2011 · ES · contact PI
Mechanisms & Consequences of Iron Accumulation in PD$265,133
P01 · FY2011 · NS · contact PI
Administrative Core$31,184
P01 · FY2011 · NS · contact PI
Mitochondrial Proteins in Parkinson's Disease$1,260,589
P01 · FY2010 · NS · contact PI
Gene-environment interactions in transgenic rat models of Parkinson disease$499,999
RC1 · FY2010 · ES · contact PI
Mechanisms & Consequences of Iron Accumulation in PD$266,447
P01 · FY2010 · NS · contact PI
Administrative Core$31,056
P01 · FY2010 · NS · contact PI
Mitochondrial Proteins in Parkinson's Disease$1,245,675
P01 · FY2009 · NS · contact PI
Gene-environment interactions in transgenic rat models of Parkinson disease$500,000
RC1 · FY2009 · ES · contact PI
Mechanisms & Consequences of Iron Accumulation in PD$265,142
P01 · FY2009 · NS · contact PI
Administrative Core$30,623
P01 · FY2009 · NS · contact PI
Screening of Parkinsonism-Inducing Neurotoxicants$200,000
U54 · FY2005 · ES
A NOVEL MODEL OF PARKINSON'S DISEASE$34,361
P51 · FY2004 · RR
GLUTAMATE IN PARKINSON'S DISEASE$34,361
P51 · FY2004 · RR
EMORY COLLABORATIVE CENTER: PD ENVIRONMENTAL RESEARCH$1,341,730
U54 · FY2003 · ES
GLUTAMATE IN PARKINSON'S DISEASE$445,792
R01 · FY2003 · NS
TRAINING IN TRANSLATIONAL RESEARCH IN NEUROLOGY$226,138
T32 · FY2003 · NS
TRAINING IN TRANSLATIONAL RESEARCH IN NEUROLOGY$101,586
T32 · FY2003 · NS
EMORY COLLABORATIVE CENTER: PD ENVIRONMENTAL RESEARCH$1,307,200
U54 · FY2002 · ES
GLUTAMATE IN PARKINSON'S DISEASE$432,806
R01 · FY2002 · NS
TRAINING IN TRANSLATIONAL RESEARCH IN NEUROLOGY$221,057
T32 · FY2002 · NS
NEW MODELS OF PD: PATHOGENESIS AND NEUROPROTECTION$0
U54 · FY2002 · ES
CORE--RESEARCH DEVELOPMENT$0
U54 · FY2002 · ES
GLUTAMATE IN PARKINSON'S DISEASE$420,892
R01 · FY2001 · NS
EXCITOTOXIC--BIOENERGETIC INTERACTIONS$239,922
R01 · FY2001 · AG
TRAINING IN TRANSLATIONAL RESEARCH IN NEUROLOGY$195,662
T32 · FY2001 · NS
GLUTAMATE IN PARKINSON'S DISEASE$410,981
R01 · FY2000 · NS
EXCITOTOXIC--BIOENERGETIC INTERACTIONS$235,341
R01 · FY2000 · AG
TRAINING IN TRANSLATIONAL RESEARCH IN NEUROLOGY$90,206
T32 · FY2000 · NS